Healthcare -
Drug Manufacturers - General - NYSE - US
$ 920.722
0.00999 %
$ 873 B
Market Cap
78.76
P/E
LLY - COST OF REVENUE
Cost of Revenue LLY - Eli Lilly and Company
8.42 B
LAST VALUE
12.68%
2 YEAR CAGR
12.26%
5 YEAR CAGR
5.49%
10 YEAR CAGR